News

June 13, 2019June 13, 2019

Levels of Thyroid Hormones May Affect Chronic Pain, Disease Severity in Endometriosis Patients, Study Suggests

News

Endometriosis patients with thyroid dysfunction may have increased risk of more intense chronic pain and increased disease severity, a study suggests. The study, “Role of thyroid dysimmunity and thyroid hormones ... Read more

June 11, 2019June 11, 2019

Endometriosis, RA, and IBD Increase Fibromyalgia Risk, Study Suggests

News

Rheumatoid arthritis (RA), endometriosis, and inflammatory bowel disease (IBD) increase the chances of a person developing fibromyalgia and chronic widespread pain later in life, a study says. The study, “A ... Read more

June 6, 2019June 6, 2019

Laparoscopic Surgery Especially Benefits Endometriosis Patients with Pelvic Pain, Study Suggests

News

Patients with severe endometriosis and pelvic pain show the most pronounced improvements in quality of life within one year after undergoing laparoscopic surgery, a study reports. The study, “Identification of ... Read more

June 4, 2019June 4, 2019

Antibiotic Metronidazole Reduces Size of Endometriosis Lesions, Mouse Study Suggests

News

The antibiotic metronidazole reduces the size of lesions in mice with endometriosis, possibly by reducing the growth of gut bacteria, researchers found. The study titled “Antibiotic therapy with metronidazole reduces ... Read more

May 28, 2019May 28, 2019

rTMS Brain Stimulation Therapy May Ease Chronic Pelvic Pain, Study Says

News

Repetitive transcranial magnetic stimulation (rTMS), a non-invasive brain stimulation technique, may be a viable therapy for women with endometriosis experiencing chronic pelvic pain for whom other treatments have failed, a ... Read more

May 24, 2019May 24, 2019

Orilissa 200 mg Twice-Daily Dose Now Available in Canada to Treat Endometriosis Pain

News

AbbVie’s oral medication Orilissa (elagolix) is now available in Canada as a 200-milligram twice-daily dose to treat moderate to severe pain caused by endometriosis. The therapy, developed by AbbVie in collaboration with Neurocrine Biosciences, ... Read more

May 17, 2019May 17, 2019

ObsEva Launches Two Key Phase 3 Trials to Confirm Efficacy of Linzagolix

News

ObsEva announced the initiation of two key Phase 3 trials to confirm the safety and efficacy of its therapy linzagolix for endometriosis-associated pelvic pain and to support the therapy’s approval ... Read more

May 7, 2019May 7, 2019

Linzagolix Offers Sustained Reduction of Endometriosis Pain, Trial Shows

News

ObsEva‘s linzagolix lessened endometriosis-associated pelvic pain and increased the quality of life of endometriosis patients in a sustained, long-term manner, according to results of the Phase 2b EDELWEISS trial. Linzagolix ... Read more

April 23, 2019April 23, 2019

Doxycycline Can Prevent Endometriosis Progression, Pilot Study Shows

News

Treatment with the common antibiotic doxycycline may help prevent progression of endometriosis lesions in women who do not respond to standard therapies, results of a pilot study suggest. The study, ... Read more